PCNA and neoplasm: Treatment with TAS-115 also resulted in a significant reduction in PCNA-positive tumour cells and MVD in SYO-1 xenografts (Fig. 6g, h and Additional file 7: Figure S7C, D and Additional file 8: Supplementary methods).